PF-04287881

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NamePF-04287881
Drug Alias NamePF-04287881PF-4287881
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A